↓ Skip to main content

Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

Overview of attention for article published in Drug Safety, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
17 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
23 Mendeley
Title
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Published in
Drug Safety, January 2019
DOI 10.1007/s40264-018-0774-8
Pubmed ID
Authors

Iosune Baraibar, Ignacio Melero, Mariano Ponz-Sarvise, Eduardo Castanon

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 17%
Professor > Associate Professor 4 17%
Other 4 17%
Student > Bachelor 3 13%
Unspecified 2 9%
Other 6 26%
Readers by discipline Count As %
Medicine and Dentistry 11 48%
Unspecified 5 22%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Environmental Science 1 4%
Nursing and Health Professions 1 4%
Other 3 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2019.
All research outputs
#1,916,852
of 13,472,087 outputs
Outputs from Drug Safety
#213
of 1,255 outputs
Outputs of similar age
#59,375
of 287,941 outputs
Outputs of similar age from Drug Safety
#3
of 27 outputs
Altmetric has tracked 13,472,087 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,255 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.